You read it here first. As part of a reorganization already under way, the drugmaker is eliminating 1,000 sales jobs - or 20 percent of its sales force - by October. Many of the 4,000 or so surviving reps, meanwhile, will be shifted to pitch different types of docs or work in other territories. A Schering-Plough spokesman confirmed the cuts.
